May 1, 2017 A Phase I/II Multicenter Study of Single-Agent Foretinib as First-Line Therapy in Patients with Advanced Hepatocellular Carcinoma.
May 1, 2017 A Phase I/II Multicenter Study of Single-Agent Foretinib as First-Line Therapy in Patients with Advanced Hepatocellular Carcinoma.
February 16, 2017 Atorvastatin inhibits the immediate-early response gene EGR1 and improves the functional profile of CD4+T-lymphocytes in acute coronary syndromes.
November 8, 2016 Phase II Trial of Angiotensin-(1-7) for the Treatment of Patients with Metastatic Sarcoma
November 4, 2016 Transgenic mouse model of IgM(+) lymphoproliferative disease mimicking Waldenstrom macroglobulinemia.
September 8, 2016 Circulating Calreticulin Is Increased in Myelofibrosis: Correlation with Interleukin-6 Plasma Levels, Bone Marrow Fibrosis, and Splenomegaly.
September 6, 2016 The combination of serum insulin, osteopontin, and hepatocyte growth factor predicts time to castration-resistant progression in androgen dependent metastatic prostate cancer- an exploratory study